Literature DB >> 2173855

Measurement of immunoreactive prothrombin precursor and vitamin-K-dependent gamma-carboxylation in human hepatocellular carcinoma tissues: decreased carboxylation of prothrombin precursor as a cause of des-gamma-carboxyprothrombin synthesis.

M Ono1, H Ohta, M Ohhira, C Sekiya, M Namiki.   

Abstract

Des-gamma-carboxyprothrombin is an abnormal prothrombin which is drastically increased in the plasma of patients with hepatocellular carcinoma. To investigate the process of the abnormal prothrombin synthesis, the amount of prothrombin precursor was measured with an enzyme-linked immunosorbent assay using a specific antibody directed to human prothrombin; the vitamin-K-dependent gamma-carboxylation of prothrombin precursor was determined in human liver tissues. The tissue content of prothrombin precursor was increased in hepatoma tissues compared with noncancerous liver tissues, while the vitamin-K-dependent carboxylation of prothrombin precursor was markedly decreased in hepatoma tissues of the patients with increased plasma des-gamma-carboxyprothrombin. The present study indicates that in hepatocellular carcinoma an increase in prothrombin precursor concentration does not induce vitamin-K-dependent carboxylase activity, which is ordinarily observed in normal liver; probably an overproduction of prothrombin precursor with reduced gamma-carboxylation causes an increase in plasma des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173855     DOI: 10.1159/000217667

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  9 in total

Review 1.  Serum markers of hepatocellular carcinoma.

Authors:  Giulia Malaguarnera; Maria Giordano; Isabella Paladina; Massimiliano Berretta; Alessandro Cappellani; Mariano Malaguarnera
Journal:  Dig Dis Sci       Date:  2010-03-26       Impact factor: 3.199

2.  Screening for hepatocellular carcinoma.

Authors:  Singal Amit; Marrero Jorge A
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-03

3.  The effect of IL-6 on the des-gamma-carboxy prothrombin synthesis in human hepatoma cells.

Authors:  M Ono; H Kohda; T Naraki; H Ohta; M Ohhira; C Sekiya; M Namiki
Journal:  Gastroenterol Jpn       Date:  1992-12

4.  Exon 2 deletion splice variant of gamma-glutamyl carboxylase causes des-gamma-carboxy prothrombin production in hepatocellular carcinoma cell lines.

Authors:  Naoki Ueda; Hidenori Shiraha; Tatsuya Fujikawa; Nobuyuki Takaoka; Yutaka Nakanishi; Mayumi Suzuki; Noriyuki Matsuo; Shigetomi Tanaka; Shin-Ichi Nishina; Masayuki Uemura; Akinobu Takaki; Yasushi Shiratori; Kazuhide Yamamoto
Journal:  Mol Oncol       Date:  2008-06-20       Impact factor: 6.603

5.  Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Authors:  Jorge A Marrero; Ziding Feng; Yinghui Wang; Mindie H Nguyen; Alex S Befeler; Lewis R Roberts; K Rajender Reddy; Denise Harnois; Josep M Llovet; Daniel Normolle; Jackie Dalhgren; David Chia; Anna S Lok; Paul D Wagner; Sudhir Srivastava; Myron Schwartz
Journal:  Gastroenterology       Date:  2009-04-09       Impact factor: 22.682

6.  Associations of Serum Tumor Biomarkers with Integrated Genomic and Clinical Characteristics of Hepatocellular Carcinoma.

Authors:  Keun Soo Ahn; Daniel R O'Brien; Yong Hoon Kim; Tae-Seok Kim; Hiroyuki Yamada; Joong-Won Park; Sang-Jae Park; Seoung Hoon Kim; Cheng Zhang; Hu Li; Koo Jeong Kang; Lewis R Roberts
Journal:  Liver Cancer       Date:  2021-09-22       Impact factor: 11.740

7.  Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States.

Authors:  Brian I Carr; Futoshi Kanke; Margaret Wise; Shinji Satomura
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

8.  Impact of PIVKA-II in diagnosis of hepatocellular carcinoma.

Authors:  Nadia I Zakhary; Sherif M Khodeer; Hanan E Shafik; Camelia A Abdel Malak
Journal:  J Adv Res       Date:  2013-01-11       Impact factor: 10.479

Review 9.  Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications.

Authors:  Massimiliano Berretta; Carla Cavaliere; Lara Alessandrini; Brigida Stanzione; Gaetano Facchini; Luca Balestreri; Tiziana Perin; Vincenzo Canzonieri
Journal:  Oncotarget       Date:  2017-02-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.